 |
|
|
| |
A Phase 2a Study of BMS-791325, an NS5B Polymerase Inhibitor, With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C Virus Infection
|
| |
| |
Reported by Jules Levin
EASL 2012
Tatum HA,1 Thuluvath PJ,2 Lawitz E,3 Martorell C,4 Demicco M,5 Cohen S,6 Rustgi V,7 Ravendhran N,8 Ghalib R,9 Hanson J,10 Zamparo J,11 Yang R,11 Hughes EA,11 Cooney E11 1Options Health Research, Tulsa, OK, USA; 2Mercy Medical Center, Baltimore, MD, USA; 3Alamo Medical Research, San Antonio, TX, USA; 4CT Martorell MD LLC, Springfield, MA, USA; 5Advanced Clinical Research, Anaheim, CA, USA; 6Loyola University Medical Center, Maywood, IL, USA; 7Metropolitan Research, Fairfax, VA, USA; 8Digestive Disease Associates, Baltimore, MD, USA; 9North Texas Research Institute, Arlington, TX, USA; 10Charlotte Gastroenterology and Hepatology, Charlotte, NC, USA; 11Bristol-Myers Squibb, Wallingford, CT, USA
|
| |
|
|
|
|
|
